"Established in 1997, the Southwest Autism Research & Resource Center (SARRC) is an internationally recognized nonprofit that conducts innovative research, provides evidence-based practices, disseminates effective training and builds inclusive communities for individuals with autism and their families. SARRC is dedicated to autism research, education, evidence-based treatment, and community outreach. Additionally, SARRC is one of the only autism organizations in the world that provides a lifetime of services for individuals and their families while also conducting cutting-edge research. SARRC’s clinical model is grounded in applied behavior analysis with a particular focus on naturalistic behavioral interventions in inclusive environments."

During the past decade, Southwest Autism Research & Resource Center conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 8 clinical trials were completed, i.e. on average, 42.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southwest Autism Research & Resource Center" #1 sponsor was "Seaside Therapeutics, Inc." with 9 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Curemark" with 4 trials sponsored, "Neuropharm" with 2 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Autism Research & Resource Center" #1 collaborator was "Autism Speaks" with 3 trials as a collaborator, "Otsuka America Pharmaceutical" with 2 trials as a collaborator, "Southwest Autism Research & Resource Center" with 2 trials as a collaborator, "State University of New York - Downstate Medical Center" with 1 trials as a collaborator and "The Emmes Company, LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Southwest Autism Research & Resource Center" are "Autism Spectrum Disorder" (10 trials), "Autism" (8 trials), "Fragile X Syndrome" (8 trials), "Autistic Disorder" (5 trials) and "Autism Spectrum Disorders" (4 trials). Many other conditions were trialed in "Southwest Autism Research & Resource Center" in a lesser frequency.

Most popular intervention types in "Southwest Autism Research & Resource Center" are "Drug" (35 trials), "Other" (5 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Aripiprazole" (4 trials), "CM-AT" (4 trials), "STX209" (3 trials) and "arbaclofen" (3 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Autism Research & Resource Center" are 37 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Southwest Autism Research & Resource Center". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Southwest Autism Research & Resource Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Autism Research & Resource Center, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".